| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.089 | 0.1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.098 | 0.1 |